These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 32750538)
1. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx. Gladstone RA; Bojang E; Hart J; Harding-Esch EM; Mabey D; Sillah A; Bailey RL; Burr SE; Roca A; Bentley SD; Holland MJ Clin Microbiol Infect; 2021 Jun; 27(6):864-870. PubMed ID: 32750538 [TBL] [Abstract][Full Text] [Related]
2. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control. Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345 [TBL] [Abstract][Full Text] [Related]
3. Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia. Burr SE; Milne S; Jafali J; Bojang E; Rajasekhar M; Hart J; Harding-Esch EM; Holland MJ; Mabey DC; Sillah A; Bailey RL; Roca A Bull World Health Organ; 2014 Jul; 92(7):490-8. PubMed ID: 25110374 [TBL] [Abstract][Full Text] [Related]
4. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375 [TBL] [Abstract][Full Text] [Related]
5. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal. Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755 [TBL] [Abstract][Full Text] [Related]
8. Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Harrison MA; Harding-Esch EM; Marks M; Pond MJ; Butcher R; Solomon AW; Zhou L; Tan N; Nori AV; Kako H; Sokana O; Mabey DCW; Sadiq ST Sex Transm Infect; 2019 Nov; 95(7):522-528. PubMed ID: 30981999 [TBL] [Abstract][Full Text] [Related]
10. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control. Seidman JC; Coles CL; Silbergeld EK; Levens J; Mkocha H; Johnson LB; Muñoz B; West SK Int J Epidemiol; 2014 Aug; 43(4):1105-13. PubMed ID: 24659584 [TBL] [Abstract][Full Text] [Related]
11. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. Gaynor BD; Holbrook KA; Whitcher JP; Holm SO; Jha HC; Chaudhary JS; Bhatta RC; Lietman T Br J Ophthalmol; 2003 Feb; 87(2):147-8. PubMed ID: 12543738 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial. Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM; Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review. O'Brien KS; Emerson P; Hooper PJ; Reingold AL; Dennis EG; Keenan JD; Lietman TM; Oldenburg CE Lancet Infect Dis; 2019 Jan; 19(1):e14-e25. PubMed ID: 30292480 [TBL] [Abstract][Full Text] [Related]
15. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. Batt SL; Charalambous BM; Solomon AW; Knirsch C; Massae PA; Safari S; Sam NE; Everett D; Mabey DC; Gillespie SH Antimicrob Agents Chemother; 2003 Sep; 47(9):2765-9. PubMed ID: 12936971 [TBL] [Abstract][Full Text] [Related]
16. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger. Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Leach AJ; Shelby-James TM; Mayo M; Gratten M; Laming AC; Currie BJ; Mathews JD Clin Infect Dis; 1997 Mar; 24(3):356-62. PubMed ID: 9114185 [TBL] [Abstract][Full Text] [Related]
18. The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma. Haug S; Lakew T; Habtemariam G; Alemayehu W; Cevallos V; Zhou Z; House J; Ray K; Porco T; Rutar T; Keenan J; Lietman TM; Gaynor BD Clin Infect Dis; 2010 Sep; 51(5):571-4. PubMed ID: 20649409 [TBL] [Abstract][Full Text] [Related]
19. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722 [TBL] [Abstract][Full Text] [Related]
20. A Cross-Sectional Study of the Availability of Azithromycin in Local Pharmacies and Associated Antibiotic Resistance in Communities in Kilosa District, Tanzania. Ansah D; Weaver J; Munoz B; Bloch EM; Coles CL; Lietman T; West SK Am J Trop Med Hyg; 2019 May; 100(5):1105-1109. PubMed ID: 30915951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]